A Prospective Open-label Multicentre Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg or Amlodipine 5 mg Monotherapy
Phase of Trial: Phase III
Latest Information Update: 17 Jan 2013
At a glance
- Drugs Amlodipine/irbesartan (Primary)
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.